- Gubretas reported a net income of 629.1 million liras for the fiscal year.
- This marks a significant turnaround from the previous year’s loss of 1.67 billion liras.
- Annual sales amounted to 48.4 billion liras, representing a 4.7% decrease compared to the previous year.
- There were no new buy, hold, or sell recommendations recorded for Gubretas during this period.
A look at Gubre Fabrikalari Tas Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 1 | |
| Growth | 2 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 2.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts evaluating Gubre Fabrikalari Tas using the Smartkarma Smart Scores indicate a varied long-term outlook. The company achieves a top score in Momentum, reflecting strong positive price trends. This suggests that investors may see potential in the company’s stock in the near future. Despite this, other factors such as Value and Dividend score lower, indicating room for improvement in these areas. Gubre Fabrikalari Tas receives moderate scores in Growth and Resilience, signaling a stable but not rapid expansion strategy, as well as decent ability to weather economic uncertainties.
Gubre Fabrikalari Tas, known for manufacturing and distributing fertilizers in Turkey, shows strengths in momentum while facing challenges in areas like value and dividend. With a focus on composite fertilizer and triple superphosphate, the company has established a solid presence in the Turkish market. Investors may need to weigh the strong momentum against lower scores in other key factors to make informed decisions about the company’s long-term prospects.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
